"Fibromatosis, Aggressive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A childhood counterpart of abdominal or extra-abdominal desmoid tumors, characterized by firm subcutaneous nodules that grow rapidly in any part of the body but do not metastasize. The adult form of abdominal fibromatosis is FIBROMATOSIS, ABDOMINAL. (Stedman, 25th ed)
- Fibromatosis, Aggressive
- Aggressive Fibromatoses
- Aggressive Fibromatosis
- Fibromatoses, Aggressive
Below are MeSH descriptors whose meaning is more general than "Fibromatosis, Aggressive".
Below are MeSH descriptors whose meaning is more specific than "Fibromatosis, Aggressive".
This graph shows the total number of publications written about "Fibromatosis, Aggressive" by people in Harvard Catalyst Profiles by year, and whether "Fibromatosis, Aggressive" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
Below are the most recent publications written about "Fibromatosis, Aggressive" by people in Profiles.
Nirogacestat, a ?-Secretase Inhibitor for Desmoid Tumors. N Engl J Med. 2023 Mar 09; 388(10):898-912.
The Prognostic Role of ß-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient Data. Ann Surg. 2021 06 01; 273(6):1094-1101.
Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Epidemiology, Diagnosis, Staging, and Histology-Specific Management Considerations. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:390-404.
Desmoid tumors of the head and neck in the pediatric population: Has anything changed? Int J Pediatr Otorhinolaryngol. 2021 Jan; 140:110511.
Adipocyte-rich CTNNB1-mutated Intramuscular Gardner Fibroma Progressing to Desmoid Fibromatosis. Pediatr Dev Pathol. 2021 Jan-Feb; 24(1):62-67.
Desmoid tumors: To treat or not to treat, That is the question. Cancer. 2020 12 15; 126(24):5213-5221.
Event-free survival in Desmoid-Type fibromatosis (DTF): A pre-post comparison of upfront surgery versus wait-and-see approach. Eur J Surg Oncol. 2021 05; 47(5):1196-1200.
Safety and efficacy of gamma-secretase inhibitor nirogacestat (PF-03084014) in desmoid tumor: Report of four pediatric/young adult cases. Pediatr Blood Cancer. 2020 10; 67(10):e28636.
PROMIS Function Scores Are Lower in Patients Who Underwent More Aggressive Local Treatment for Desmoid Tumors. Clin Orthop Relat Res. 2020 03; 478(3):563-577.
Bone Sarcomas and Desmoids. Hematol Oncol Clin North Am. 2020 02; 34(1):177-188.